Authors:
Hoffmann, MM
Scharnagl, H
Panagiotou, E
Banghard, WT
Wieland, H
Marz, W
Citation: Mm. Hoffmann et al., Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomenulopathy, J AM S NEPH, 12(3), 2001, pp. 524-530
Authors:
Hoffmann, MM
Scharnagl, H
Koster, W
Winkler, K
Wieland, H
Marz, W
Citation: Mm. Hoffmann et al., Apolipoprotein E1 Baden (Arg(180)-> Cys) - A new apolipoprotein E variant associated with hypertriglyceridemia, CLIN CHIM A, 303(1-2), 2001, pp. 41-48
Authors:
Marz, W
Scharnagl, H
Abletshauser, C
Hoffmann, MM
Berg, A
Keul, J
Wieland, H
Baumstark, MW
Citation: W. Marz et al., Fluvastatin lowers atherogenic dense low-density lipoproteins in postmenopausal women with the atherogenic lipoprotein phenotype, CIRCULATION, 103(15), 2001, pp. 1942-1948
Authors:
Scharnagl, H
Schinker, R
Gierens, H
Nauck, M
Wieland, H
Marz, W
Citation: H. Scharnagl et al., Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylglycerides in HepG2 cells, BIOCH PHARM, 62(11), 2001, pp. 1545-1555
Authors:
Gierens, H
Nauck, M
Roth, M
Schinker, R
Schurmann, C
Scharnagl, H
Neuhaus, G
Wieland, H
Marz, W
Citation: H. Gierens et al., Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements, ART THROM V, 20(7), 2000, pp. 1777-1783
Authors:
Scharnagl, H
Schliack, M
Loser, R
Nauck, M
Gierens, H
Jeck, N
Wieland, H
Gross, W
Marz, W
Citation: H. Scharnagl et al., The effects of lifibrol (K12.148) on the cholesterol metabolism of cultured cells: evidence for sterol independent stimulation of the LDL receptor pathway, ATHEROSCLER, 153(1), 2000, pp. 69-80
Authors:
Nauck, MS
Scharnagl, H
Nissen, H
Schurmann, C
Mattern, D
Nauck, MA
Wieland, H
Marz, W
Citation: Ms. Nauck et al., FH-Freiburg: a novel missense mutation (C317Y) in growth factor repeat A of the low density lipoprotein receptor gene in a German patient with homozygous familial hypercholesterolemia, ATHEROSCLER, 151(2), 2000, pp. 525-534
Authors:
Winkler, K
Schaefer, JR
Klima, B
Nuber, C
Friedrich, I
Koster, W
Gierens, H
Scharnagl, H
Soufi, M
Wieland, H
Marz, W
Citation: K. Winkler et al., HDL steady state levels are not affected, but HDL apoA-I turnover is enhanced by Lifibrol in patients with hypercholesterolemia and mixed hyperlipidemia, ATHEROSCLER, 150(1), 2000, pp. 113-120
Authors:
Scharnagl, H
Tisljar, U
Winkler, K
Huttinger, M
Nauck, MA
Gross, W
Wieland, H
Ohm, TG
Marz, W
Citation: H. Scharnagl et al., The beta A4 amyloid peptide complexes to and enhances the uptake of beta-very low density lipoproteins by the low density lipoprotein receptor-related protein and heparan sulfate proteoglycans pathway, LAB INV, 79(10), 1999, pp. 1271-1286
Authors:
Winkler, K
Scharnagl, H
Tisljar, U
Hoschutzky, H
Friedrich, I
Hoffmann, MM
Huttinger, M
Wieland, H
Marz, W
Citation: K. Winkler et al., Competition of A beta amyloid peptide and apolipoprotein E for receptor-mediated endocytosis, J LIPID RES, 40(3), 1999, pp. 447-455
Authors:
Fisher, E
Scharnagl, H
Hoffmann, MM
Kusterer, K
Wittmann, D
Wieland, H
Gross, W
Marz, W
Citation: E. Fisher et al., Mutations in the apolipoprotein (apo) B-100 receptor-binding region: Detection of apo B-100 (Arg(3500)--> Trp) associated with two new haplotypes andevidence that apo B-100 (Glu(3405)-> Gln) diminishes receptor-mediated uptake of LDL, CLIN CHEM, 45(7), 1999, pp. 1026-1038
Authors:
Kusterer, K
Pohl, T
Fortmeyer, HP
Marz, W
Scharnagl, H
Oldenburg, A
Angermuller, S
Fleming, I
Usadel, KH
Busse, R
Citation: K. Kusterer et al., Chronic selective hypertriglyceridemia impairs endothelium-dependent vasodilatation in rats, CARDIO RES, 42(3), 1999, pp. 783-793
Citation: Tg. Ohm et al., Apolipoprotein E isoforms and the development of low and high Braak stagesof Alzheimer's disease-related lesions, ACT NEUROP, 98(3), 1999, pp. 273-280